BlackRock Health (BMEZ) Fundamental Analysis: Revenue, Earnings & Valuation

2.20 / 10

Underperform

Fundamental rating is Underperform with a 2.2/10 score. Inventory turnover days and ratio are strong, yet accounts receivable turnover and diluted EPS growth are weak. Gross profit margin is decent, but overall financial health remains subpar.

Analysis Checks(6/9)

Inventory turnover ratio

Value106.57

Score2/3

Weight11.95%

1M Return1.46%

Gross profit margin (%)

Value48.34

Score2/3

Weight12.07%

1M Return1.44%

Accounts receivable turnover ratio

Value23.61

Score1/3

Weight10.92%

1M Return1.33%

Rate of return on total assets (%)

Value-7.83

Score2/3

Weight11.98%

1M Return1.48%

Fixed assets turnover ratio

Value9771.06

Score2/3

Weight9.30%

1M Return1.15%

Annualized return on total assets (%)

Value-7.83

Score2/3

Weight11.98%

1M Return1.48%

Diluted earnings per share (YoY growth rate %)

Value31.14

Score0/3

Weight7.44%

1M Return0.90%

Inventory turnover days

Value210.83

Score3/3

Weight12.16%

1M Return1.49%

Current assets / Total assets (%)

Value46.64

Score1/3

Weight12.21%

1M Return1.45%

Is BMEZ undervalued or overvalued?

BMEZ scores 2.20/10 on fundamentals and holds a Premium valuation at present. Backed by its 7.31% ROE, 833.81% net margin, 8.76 P/E ratio, 0.82 P/B ratio, and 599.17% earnings growth, these metrics solidify its Underperform investment rating.